Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIVALIRUDIN for Heparin-induced thrombocytopenia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 39 adverse event reports in the FDA FAERS database where BIVALIRUDIN was used for Heparin-induced thrombocytopenia.

Most Reported Side Effects for BIVALIRUDIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 148 17.6% 12 72
Haemorrhage 79 9.4% 7 22
Off label use 73 8.7% 9 35
Thrombosis in device 63 7.5% 9 8
Vascular stent thrombosis 63 7.5% 14 15
Heparin-induced thrombocytopenia 61 7.3% 8 38
Thrombosis 61 7.3% 9 13
Coagulation time abnormal 42 5.0% 3 2
Gastrointestinal haemorrhage 40 4.8% 6 11
Coronary artery thrombosis 33 3.9% 7 4
Cardiac arrest 28 3.3% 25 16
Haemorrhage intracranial 20 2.4% 7 6
Kounis syndrome 20 2.4% 15 11
Acute myocardial infarction 19 2.3% 7 10
Ventricular fibrillation 19 2.3% 13 12

Other Indications for BIVALIRUDIN

Anticoagulant therapy (262) Percutaneous coronary intervention (159) Product used for unknown indication (134) Thrombosis prophylaxis (33) Thrombosis (15) Catheterisation cardiac (14) Acute coronary syndrome (13) Prophylaxis (13) Coronary angioplasty (11) Deep vein thrombosis (11)

Other Drugs Used for Heparin-induced thrombocytopenia

ARGATROBAN (169) FONDAPARINUX (51) DANAPAROID (34) APIXABAN (16) RIVAROXABAN (15) HUMAN IMMUNOGLOBULIN G (11) NOVASTAN (7) RITUXIMAB (6) WARFARIN (5)

Related Pages

BIVALIRUDIN Full Profile All Heparin-induced thrombocytopenia Drugs BIVALIRUDIN Demographics BIVALIRUDIN Timeline